News
nRichDX to Exhibit and Present at the AMP2024 Annual Meeting
[link to press release on PRNewswire] News provided by nRichDX Oct 17, 2024, 08:39 ET The emerging leader in liquid biopsy sample prep will have the latest automation & kits at exhibit booth #1321 VANCOUVER, BC, Oct. 17, 2024 /PRNewswire/ -- nRichDX®, best known for its Revolution Sample Prep System™ for liquid biopsy, will display its latest products, present new data, and exhibit at the Association for Molecular Pathology (AMP) Annual Meeting 2024. The meeting is November 19-23 at the Vancouver Convention Centre, in Vancouver, British Columbia, Canada. The meeting is devoted to exploring and recognizing the latest discoveries in molecular pathology and precision medicine. nRichDX will exhibit in booth #1321, and its solutions used in at least three technical posters. The exhibits open at 11:15 AM on Thursday, November 21, and close at 1:30 PM on Saturday, November 23....
nRichDX to Debut New Products & Present Latest Research at AACR 2024 Annual Meeting this April
nRichDX to Debut New Products & Present Latest Research at AACR 2024 Annual Meeting this April The emerging leader in liquid biopsy sample prep to showcase new instruments & kits at conference booth; Share advancements in liquid biopsy assays via three poster presentations PR Newswire...
nRichDX to Exhibit at the Association for Molecular Pathology (AMP) 2023 Annual Meeting & Expo
...
Revolution CTC Enrichment Kit (Epithelial Origin)
nRichDX Launches New CTC Enrichment Kit NEWS PROVIDED BY nRichDX 29 Sep, 2023, 08:57 ET [link to PRNewswire release] The Revolution CTC Enrichment Kit (Epithelial Cell Origin)™ is nRichDX's latest product to advance liquid biopsy development....
Agena Bioscience and nRichDX Announce Commercial Partnership
...
nRichDX Launches Two New Products for Liquid Biopsy Applications
The Revolution Circulating Free Total Nucleic Acid (cfTNA) Kit™ and cfDNA Reference Standard products are designed to advance liquid biopsy application development....
nRichDX and Eppendorf to Jointly Present at ESHG 2022 Meeting
IRVINE, California, April 14, 2022 – nRichDX and Eppendorf will present data from the Revolution Semi-Automated Workflow™ powered by the epMotion® 5073 instrument at the upcoming European Society for Human Genetics (ESHG) 2022 Conference in Vienna, Austria on Saturday, June 11, 2022, from 10:00 am – 11:30 am CET....
nRichDX Launches Revolution Sample Prep™ Service
New cfDNA and ctDNA extraction service for researcher-provided blood and urine samples with TAT of one week or less....
nRichDX Introduces In Kind Grants for Academic Researchers
Grant program for qualified and approved cfDNA Researchers in academia and non-profit organizations for the purpose of advancing their research projects by providing more cfDNA and ctDNA than is available using current methods. IRVINE, Calif., Jun 8, 2021– nRichDX® Inc. announces the Revolution™ Sample Prep Grant Program which provides grants of Processor hardware and Revolution kits to researchers extracting circulating free DNA and circulating tumor DNA in their work. The Revolution Sample Prep System enables the extraction of more cfDNA and ctDNA from samples of blood or urine. The System extracts from 1 mL - 20 mL in a single extraction and unlike other methods, does not require cfDNA yield-lowering sample pooling, concentration, or transfer steps....
Events
Association for Molecular Pathology (AMP) 2024 Annual Meeting
nRichDX to Exhibit & Present at AMP 2024 Annual Meeting, November 21-23 The emerging leader in liquid biopsy sample prep will have the latest automation & kits at exhibit booth #1321 VANCOUVER, BC, Oct. 17, 2024 /PRNewswire/ -- nRichDX®, will present new data, and exhibit at the Association for Molecular Pathology (AMP) Annual Meeting 2024. The meeting is November 19-23 at the Vancouver Convention Centre, in Vancouver, British Columbia, Canada. nRichDX will exhibit in booth #1321. The exhibits open at 11:15 AM on Thursday, November 21, and close at 1:30 PM on Saturday, November 23. AMP Meeting attendees working in liquid biopsy and the extraction of analytes including ctDNA, ctRNA, cell-free total nucleic acid (cfTNA), and the enrichment of circulating tumor cells (CTCs) are encouraged to schedule a meeting or visit the nRichDX booth to see the latest liquid biopsy sample prep solutions and learn more about how extracting higher yields of these analytes can increase assay performance through better sensitivity and earlier detection of targeted oncology markers. At least three posters planned for the meeting will include nRichDX solutions: Enhanced Extraction and Preservation of Circulating Cell-Free RNA from 50 mL Cell-Free Urine, presented in collaboration with Agilent Technologies The Mutational Landscape of Circulating Tumor Cells in Pancreatic Cancer, presented in collaboration with Dartmouth Hitchcock Medical Center Clinical Validation of Cell-free DNA (cfDNA) Extraction from Whole Blood Plasma using the nRichDX® Revolution Max 20 Kit and Sample Prep System, presented in collaboration with Dartmouth Hitchcock Medical Center AMP attendees are encouraged to schedule an appointment to meet with nRichDX people at the meeting or schedule an in-booth discussion and demo. For more information about nRichDX's schedule at the AMP 2024 Annual Meeting, please visit www.nrichdx.com/amp2024. [AMP 2024 Annual Meeting website] About nRichDX: nRichDX® provides kits and automated solutions for isolating cfDNA, cfRNA, and CTCs. The patented Revolution Sample Prep System™ is engineered specifically for liquid biopsy applications and isolating analytes from blood, plasma, urine, and other biofluids. It is the first and only high-yield, high-recovery, IVD-labeled sample prep platform to process from as little as 1 mL to 100 mL in a single extraction using the company's patented Revolution nRicher™ Cartridges. Unlike other methods, Revolution sample prep doesn't require yield-lowering sample preconcentration, eluate pooling, sample transfer, or sample re-elution steps. nRichDX helps solve one of precision medicine's greatest problems – – inaccurate or incomplete diagnostic results for liquid biopsy-based applications due to insufficient analyte. nrichdx.com....
AACR 2024 Bladder Cancer Meeting
nRichDX's VP of R&D Will Present a Poster at the AACR Special Conference in Cancer Research:Bladder Cancer Transforming the Field Meeting. The meeting will be held May 17-20, 2024 at the Le Méridien Charlotte Hotel in Charlotte, North Carolina....
NIH/NCI LBx Meeting May 13-14 2024
nRichDX's Chief Science Officer Will Attend and Present at the "New Frontiers in Liquid Biopsy Meeting - Data, Technology and Translational Potential" The "New Frontiers in Liquid Biopsy Meeting - Data, Technology and Translational Potential" will be held May 13-14, 2024 at the National Institutes of Health's Bethesda, Maryland Campus in the Natcher Auditorium in Building 45....
nRichDX Exhibiting at the AACR 2024 Annual Meeting, April 7-10 2024
See nRichDX at the AACR 2024 Annual Meeting, April 7-10 2024 in San Diego, California....
nRichDX to Exhibit at AMP2023 Annual Meeting & Expo
See nRichDX at the AMP 2023 Annual Meeting & Expo, November 14-18 2023 in Salt Lake City, Utah....
Dr. Klaus Pantel Webinar
nRichDX is hosting a webinar with keynote presenter Dr. Klaus Pantel on April 12 2023 titled, Current Perspectives on Liquid Biopsy Technologies...